Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Rosuvastatin 20 mg vs Crestor 20 mg in Healthy Thai Volunteers Under Fasting Conditions
TCTR20191114003Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia and combined dyslipidaemia (2 arms), sponsored by International Bio Service. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on TCTR20191114003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191114003.